Elevated concentration of cerebrospinal fluid tissue transglutaminase in Parkinson's disease indicating apoptosis

Movement Disorders

Volumn 19, Issue 10, 2004, Pages 1252-1254

  Vermes, Istvan ^a   Jansen Steur, Ernst N H ^a   Jirikowski, Gustav F ^b   Haanen, Clemens ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Apoptosis; Cerebrospinal fluid; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AGED; APOPTOSIS; ARTICLE; BRADYKINESIA; CELL DEATH; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; COGNITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; SLEEP DISORDER; SOMNOLENCE; SYMPTOM; TREMOR;

AGED; ALZHEIMER DISEASE; APOPTOSIS; FEMALE; HUMANS; MALE; PARKINSON DISEASE; TRANSGLUTAMINASES;

EID: 7244254372     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20197     Document Type: Article

References (14)

1. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407:802-809.
2. Tatton NA, Machlean-Fraser A, Tatton WG, Perl DP, Olanow CW. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol 1998;44(Suppl.): 142-148.
3. Vermes I, Steur EN, Reutelingsperger C, Haanen C. Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause. Mov Disord 1999;14:1008-1010.
4. Fesus L, Davies PJA, Piacentini M. Apoptosis: molecular mechanism in programmed cell death. Eur J Cell Biol 1991;56:170-177.
5. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243:167-190.
6. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002;27:534-539.
7. Volokhina EB, Hulshof R, Haanen C, Vermes I. Tissue transglutaminase mRNA expression in apoptotic cell death. Apoptosis 2003;8:673-679.
8. Sarvari M, Fesus L, Nemes Z. Transglutaminase-mediated crosslinking of neural proteins in Alzheimer's diseases and other primary dementias. Drug Dev Res 2002;56:458-472.
9. Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM. Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 2003;100: 2047-2052.
10. Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G. Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease. Neurobiol Dis 2002;11:106-110.
11. Bonelli RM, Aschoff A, Jirikowski G. Cerebrospinal fluid tissue transglutaminase in vascular dementia. J Neurol Sci 2002;203: 207-209.
12. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003;348:1365-1375.
13. Burke RE. Programmed cell death and Parkinson's disease. Mov Disord 1998;13:17-23.
14. Ziv I, Melamed E. Role of apoptosis in the pathogenesis of Parkinson's disease: a novel therapeutic opportunity? Mov Disord 1998;13:865-870.